Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER × Ifosfamide × Clear all

Phase

Phase 2 119 Phase 1/2 28 Phase 3 25 Phase 1 17 Phase NA 16 Phase 4 10 Phase EARLY_PHASE1 5 Phase 2/3 1

Status

Sponsor Class

NIH 3 OTHER_GOV 1 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Cisplatin 53 Cyclophosphamide 42 Fluorouracil 41 Oxaliplatin 36 Capecitabine 35 Docetaxel 34 Drug Therapy 32 Radiotherapy 31 Gemcitabine 30 Paclitaxel 25 Carboplatin 23 Dexamethasone 22 Leucovorin 21 Etoposide 17 Doxorubicin 17 apatinib 16 Methotrexate 16 Cytarabine 16 Radiation 13 Magnetic Resonance Spectroscopy 13 Epirubicin 13 Busulfan 13 Surgical Procedures, Operative 12 Neoadjuvant Therapy 12 Letrozole 12 Decitabine 12 Bevacizumab 12 Saline Solution 11 venetoclax 10 fludarabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡